BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38254675)

  • 21. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
    Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
    Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample.
    Xu X; Hilal S; Collinson SL; Chan QL; Yi Chong EJ; Ikram MK; Venketasubramanian N; Cheng CY; Wong TY; Chen CL
    J Alzheimers Dis; 2016 Apr; 52(3):1021-8. PubMed ID: 27079726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.
    Llorens F; Hermann P; Villar-Piqué A; Diaz-Lucena D; Nägga K; Hansson O; Santana I; Schmitz M; Schmidt C; Varges D; Goebel S; Dumurgier J; Zetterberg H; Blennow K; Paquet C; Baldeiras I; Ferrer I; Zerr I
    Nat Commun; 2020 Jan; 11(1):619. PubMed ID: 32001681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.
    Pettigrew C; Soldan A; Zhu Y; Cai Q; Wang MC; Moghekar A; Miller MI; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M
    Neurobiol Aging; 2020 Apr; 88():33-41. PubMed ID: 31932050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementia.
    Chua XY; Torta F; Chong JR; Venketasubramanian N; Hilal S; Wenk MR; Chen CP; Arumugam TV; Herr DR; Lai MKP
    Alzheimers Res Ther; 2023 Dec; 15(1):214. PubMed ID: 38087395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.
    Erkinjuntti T
    Int J Clin Pract Suppl; 2001 May; (120):14-23. PubMed ID: 11406922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
    Otoki Y; Yu D; Shen Q; Sahlas DJ; Ramirez J; Gao F; Masellis M; Swartz RH; Chan PC; Pettersen JA; Kato S; Nakagawa K; Black SE; Swardfager W; Taha AY
    J Alzheimers Dis; 2023; 93(2):665-682. PubMed ID: 37092220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.
    Chong JR; Hilal S; Ashton NJ; Karikari TK; Reilhac A; Vrooman H; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
    Alzheimers Dement (Amst); 2023; 15(1):e12396. PubMed ID: 36994314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study.
    Jonesco DS; Karsdal MA; Henriksen K
    PLoS One; 2020; 15(6):e0234632. PubMed ID: 32559242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Verdelho A; Madureira S; Pantoni L; Inzitari D; Erkinjuntti T; Crisby M; Waldemar G; Schmidt R; Fazekas F; Scheltens P
    Stroke; 2005 Oct; 36(10):2116-20. PubMed ID: 16141425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.